Cargando…

Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis

Multiple sclerosis is an autoimmune disease that is caused by the interplay of genetic, particularly the HLA-DR15 haplotype, and environmental risk factors. How these etiologic factors contribute to generating an autoreactive CD4(+) T cell repertoire is not clear. Here, we demonstrate that self-reac...

Descripción completa

Detalles Bibliográficos
Autores principales: Jelcic, Ivan, Al Nimer, Faiez, Wang, Jian, Lentsch, Verena, Planas, Raquel, Jelcic, Ilijas, Madjovski, Aleksandar, Ruhrmann, Sabrina, Faigle, Wolfgang, Frauenknecht, Katrin, Pinilla, Clemencia, Santos, Radleigh, Hammer, Christian, Ortiz, Yaneth, Opitz, Lennart, Grönlund, Hans, Rogler, Gerhard, Boyman, Onur, Reynolds, Richard, Lutterotti, Andreas, Khademi, Mohsen, Olsson, Tomas, Piehl, Fredrik, Sospedra, Mireia, Martin, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191934/
https://www.ncbi.nlm.nih.gov/pubmed/30173916
http://dx.doi.org/10.1016/j.cell.2018.08.011
Descripción
Sumario:Multiple sclerosis is an autoimmune disease that is caused by the interplay of genetic, particularly the HLA-DR15 haplotype, and environmental risk factors. How these etiologic factors contribute to generating an autoreactive CD4(+) T cell repertoire is not clear. Here, we demonstrate that self-reactivity, defined as “autoproliferation” of peripheral Th1 cells, is elevated in patients carrying the HLA-DR15 haplotype. Autoproliferation is mediated by memory B cells in a HLA-DR-dependent manner. Depletion of B cells in vitro and therapeutically in vivo by anti-CD20 effectively reduces T cell autoproliferation. T cell receptor deep sequencing showed that in vitro autoproliferating T cells are enriched for brain-homing T cells. Using an unbiased epitope discovery approach, we identified RASGRP2 as target autoantigen that is expressed in the brain and B cells. These findings will be instrumental to address important questions regarding pathogenic B-T cell interactions in multiple sclerosis and possibly also to develop novel therapies.